Office of Research COVID-19 Extramural Research Funding - Office of Research

COVID-19 Extramural Research Funding

Return to COVID-19 Research Working Group website

COVID-19 research funding opportunities relevant to UC Davis researchers will be added to this table as they are released by federal and state funding agencies, foundations, non-profits and industry partners. Please use the sorting and search tools below to find the opportunities most useful to you. Suggest additional entries by emailing msparling@ucdavis.edu.

The Office of Foundation and Corporate Engagement provides support for your proposals to foundations and corporate sponsors (fce@ucdavis.edu). All proposals for sponsored projects funded by government or non-profit sponsors are reviewed and authorized for submission by the Sponsored Programs Office (SPO). SPO is currently offering an expedited review process for all COVID-19 related proposals. Contact them at proposals@ucdavis.edu.

SponsorSponsor TypeProgram TitleLinkSponsor DeadlinePosted OnFunding Area(s)DescriptionAmount
Centers for Disease Control (CDC)Non-NIH FederalStrengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globallyhttps://ucdavis.infoready4.com/#competitionDetail/182951802/22/2021*11/23/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis is a limited submission opportunity. Please visit the link for more information.
Centers for Disease Control (CDC)Non-NIH FederalUS Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Childrenhttps://ucdavis.infoready4.com/#competitionDetail/182951602/08/2021*11/23/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Policy, Economics, and LaborThis is a limited submission opportunity. Please visit the link for more information.
XPRIZE FoundationIndustry SponsorPandemic Response Challengehttps://www.xprize.org/challenge/pandemicresponse12/08/202011/23/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Policy, Economics, and LaborThe Pandemic Response Challenge is a challenge that focuses on the development of data-driven AI systems to predict COVID-19 infection rates and prescribe Intervention Plans (IPs) that regional governments, communities, and organizations can implement to minimize harm when reopening their economies.
National Institutes of Health (NIH-NIEHS)NIHNotice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and Their Communitieshttps://grants.nih.gov/grants/guide/notice-files/NOT-ES-21-002.html12/31/202011/23/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this supplement is to provide support for successful applicants to develop partnerships with local worker centers and community organizations specifically targeting under served and disadvantaged communities with higher than average COVID-19 transmission rates.
Centers for Disease Control (CDC)Non-NIH FederalStrengthening Public Health Research and Implementation Science (Operations Research) to Control and Eliminate Infectious Diseases Globallyhttps://www.grants.gov/web/grants/view-opportunity.html?oppId=32970002/22/202111/17/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Policy, Economics, and LaborThe purpose of this notice of funding opportunity is to: Conduct and monitor epidemiologic and laboratory-based science, surveillance, and research related to COVID-19 and other global public health threats in Africa, Southeast Asia, Eastern Europe and Central Asia, and the Middle East and North Africa (MENA), including, but not limited to, assessments of the extent of pathogen exposures or transmission based on serologic testing, improved understanding of immune responses to infectious pathogens, and assessments of various approaches to collecting and analyzing the results of serologic testing; and, Incorporate the results of these public health activities into operational disease detection, prevention, and response or control programs in regions noted above, strengthen public health capacity as outlined in the Global Health Security Agenda, and disseminate findings across the region, with partners, and globally.2000000
Robert Wood Johnson Foundation (RWJF)FoundationHealth Data for Action: Data Access Awardhttps://www.rwjf.org/en/library/funding-opportunities/2020/health-data-for-action-data-access-award.html?rid=0034400001zl9ngAAA&et_cid=229685904/15/202111/16/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Policy, Economics, and LaborFor more information about this opportunity, please contact Traci Galbaugh (tlgalbaugh@ucdavis.edu), Senior Director of Foundation EngagementNo financial award will be given with these awards, which are solely for data access.
Centers for Disease Control (CDC)Non-NIH FederalConducting Public Health Research in Ethiopiahttps://ucdavis.infoready4.com/#competitionDetail/182889102/19/2021*11/16/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis is a limited submission opportunity. Please visit the link for more information.The estimated total funding available, including direct and indirect costs, for the entire 5-year project period is $5,000,000
National Institutes of Health (NIH-NICHD)NIHNotice of Special Interest (NOSI): Research on Rehabilitation Needs Associated with the COVID-19 Pandemichttps://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-031.html05/08/202311/16/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Notice of Special Interest is to encourage applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation: 1) Encourage research to address the rehabilitation needs of survivors of COVID-19; 2) Understand the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions; and 3) Understand the social, behavioral, economic, and health impact of the COVID-19 pandemic and the associated mitigation actions on people with physical disabilities
National Institutes of Health (NIH-NIGMS)NIHNotice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease (COVID-19) and the Causative Virus SARS-CoV-2https://grants.nih.gov/grants/guide/notice-files/NOT-GM-20-025.html02/05/202111/16/2020Epidemiology / Public Health; Life SciencesNIGMS will accept the submission of applications for Competitive Revisions to active grants to address only the following research areas of interest: Incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive models for the spread of SARS-CoV-2 and other related infectious agents (all relevant grants).
Repurposing or modification of diagnostic tools currently under development to enable rapid detection of SARS-CoV-2 infection (SBIR/STTR grants only). Rapid development of potential therapeutic agents for COVID-19 (SBIR/STTR only).
National Institutes of Health (NIH-NIAAA)NIHNotice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease (COVID-19) within the Mission of NIAAAhttps://grants.nih.gov/grants/guide/notice-files/NOT-AA-20-011.html04/15/202111/16/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe impact of the COVID-19 pandemic on the nation is vast, especially on health and well-being. Research suggests that alcohol consumption tends to increase during times of duress and uncertainty such as disasters and other traumatic events, and as such alcohol is often misused to cope with stress, anxiety, and other uncomfortable emotions. In addition, the misuse of alcohol to cope with the stress as a result of physical distancing and other policy measures, and a lack of access to supportive social networks and treatment for people with pre-existing alcohol use disorder (AUD) are significant concerns during the pandemic. These outcomes are particularly challenging with respect to COVID-19 because alcohol misuse can interfere with normal immune system function and elevate susceptibility to viral infections of the respiratory system. Alcohol-associated damage to the liver, heart, and other organs may also complicate health outcomes in individuals with COVID-19. These myriad physical and behavioral health outcomes related to alcohol and COVID-19 present a range of urgent research needs and opportunities.Application budgets are generally limited to no more than $100,000 direct costs per year. Should the proposed research require a higher budget, the applicant should consult with the program official assigned to the parent award. Permission to exceed $100,000 must be acquired from NIAAA's Office of Extramural Activities prior to submission.
National Institutes of Health (NIH-NIDCD)NIHNotice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disordershttps://grants.nih.gov/grants/guide/notice-files/NOT-DC-20-008.html09/08/202211/16/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborCoronavirus Disease 2019 (COVID-19) is a recently emerged human disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is a paucity of data on the impact of SARS-CoV-2 on the sensory and communicative functions within the scientific mission areas of NIDCD. NIDCD invites applications for research on COVID-19 in relation to NIDCD's scientific programs of hearing, balance, taste, smell, voice, speech and language (HBTSVSL). Given the early stage of COVID-19 research, it is critical that there is a strong premise for research proposals submitted in response to this NOSI. When appropriate, NIDCD encourages multi-disciplinary approaches to move the research beyond in vitro and animal models.
National Institutes of Health (NIH-NIA)NIHNotice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)https://grants.nih.gov/grants/guide/notice-files/NOT-AG-20-022.html05/01/202111/16/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19). The mission of NIA is to support and conduct genetic, biological, clinical, behavioral, social, and economic research on aging. This NOSI supports mission critical areas of research for NIA as they relate to the COVID-19 pandemic.
National Institutes of Health (NIH-NIEHS)NIHNotice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)https://grants.nih.gov/grants/guide/notice-files/NOT-ES-20-015.html05/03/202111/16/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIEHS is issuing this Notice of Special Interest (NOSI) to address the urgent need for mission-relevant research to understand the impact of environmental exposures on Coronavirus Disease 2019 (COVID-19) and its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). NIEHS is particularly interested in applications that will provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies.
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Projecthttps://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-129.html07/13/202111/13/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIH is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in individuals with Down syndrome in conjunction with the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project.
National Institutes of Health (NIH-NIAID)NIHEmergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projectshttps://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-002.html01/11/202111/13/2020Epidemiology / Public Health; Life SciencesNIAID is issuing this Notice of Special Interest (NOSI) to highlight the critical need to develop prophylactic vaccines able to provide broad and durable protection against coronaviruses (CoVs), especially SARS-CoV-2 and others with pandemic potential. NIAID is particularly interested in highly collaborative, multi-disciplinary Program Projects (P01s) that incorporate understanding of CoV virology and immunology, immunogen design, and innovative vaccine and adjuvant platforms and technologies to discover, design, and develop pan-coronavirus (pan-CoV) vaccine candidates that provide broad protective immunity to multiple CoV strains.
Centers for Disease Control (CDC)Non-NIH FederalConducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services to Mitigate Morbidity and Mortalityhttps://ucdavis.infoready4.com/#competitionDetail/182868801/18/2021*11/13/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis is a limited submission opportunity. Please visit the link for more information.
Health Resources and Services Administration (HRSA)Non-NIH FederalNational Telehealth Resource Center Programhttps://researchfunding.ucdavis.edu/#announcement/2717901/21/202111/09/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThis is a limited submission opportunity. Please visit the link for more information.
Health Resources and Services Administration (HRSA)Non-NIH FederalRegional Telehealth Resource Center Programhttps://researchfunding.ucdavis.edu/#announcement/2717801/21/2021*11/09/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThis is a limited submission opportunity. Please visit the link for more information.
Health Resources and Services Administration (HRSA)Non-NIH FederalRural Health Clinic Technical Assistance Programhttps://researchfunding.ucdavis.edu/#announcement/2716312/21/2020*11/09/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThis is a limited submission opportunity. Please visit the link for more information.
Administration for Community Living (ACL-DHHS)Non-NIH FederalAdvanced Rehabilitation Research Training (ARRT) Program - Employmenthttps://acl.gov/grants/open-opportunities12/18/202011/09/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThe purpose of NIDILRR’s ARRT program is to provide advanced research training and experience to individuals with doctorates, or similar advanced degrees, who have clinical or other relevant experience. ARRT projects train rehabilitation researchers, including researchers with disabilities, with particular attention to research areas that support the implementation and objectives of the Rehabilitation Act, and that improve the effectiveness of services authorized under the Rehabilitation Act. ARRT projects under this opportunity announcement must provide advanced research training to eligible individuals to enhance their capacity to conduct high-quality multidisciplinary disability and rehabilitation research to improve outcomes for individuals with disabilities in NIDILRR’s major domain of employment.
Administration for Community Living (ACL-DHHS)Non-NIH FederalAdvanced Rehabilitation Research Training (ARRT) Program - Community Living and Participationhttps://acl.gov/grants/open-opportunities12/18/202011/09/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThe purpose of NIDILRR’s ARRT program is to provide advanced research training and experience to individuals with doctorates, or similar advanced degrees, who have clinical or other relevant experience. ARRT projects train rehabilitation researchers, including researchers with disabilities, with particular attention to research areas that support the implementation and objectives of the Rehabilitation Act, and that improve the effectiveness of services authorized under the Rehabilitation Act. ARRT projects under this opportunity announcement must provide advanced research training to eligible individuals to enhance their capacity to conduct high-quality multidisciplinary disability and rehabilitation research to improve outcomes for individuals with disabilities in NIDILRR’s major domain of community living and participation.
National Institutes of Health (NIH-NIDA)NIHNotice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infectionhttps://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-084.html09/08/202411/09/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThe purpose of this notice is to communicate NIDA’s interest in supporting research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection.
National Institutes of Health (NIH-NHLBI)NIHNotice of Special Interest (NOSI): The Influence of Host Resiliance on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-814.html07/06/202411/09/2020Epidemiology / Public Health; Life SciencesThe purpose of this Notice of Special Interest (NOSI) is to inform potential applicants of the special interest of NHLBI in research to understand host resilience as a critical determinant of outcomes in acute respiratory distress syndrome (ARDS) /acute lung injury (ALI).
National Institutes of Health (NIH-NICHD)NIHNotice of Special Interest (NOSI): Emerging Viral Infections and Their Impact on the Male and Female Reproductive Tracthttps://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-021.html07/16/202311/09/2020Epidemiology / Public Health; Life SciencesThe purpose of this Notice is to invite applications proposing cutting-edge research on emerging viral infections that are thought to primarily impact non-reproductive sites, at least at initial presentation, but may also affect the male and/or female reproductive tract. The recent global outbreak of the novel coronavirus, SARS-CoV-2, is not an anomaly and will most likely not be the last virus occurrence. Today, infectious diseases are emerging and reemerging more quickly than ever before. In the last four-five years alone, two viral infections, one caused by the Zika virus (ZIKV) and the other caused by a SARS-CoV-2 (Covid19), have spread world-wide, resulting in death, severe disease with yet, unknown, long-term morbidities., or severe birth defects to the new-born. Both ZIKV and SARS-CoV-2 infections may affect male and/or female reproductive systems in addition to other non-reproductive sites. Therefore, it becomes essential to investigate possible effects of emerging viruses on reproductive tissues and cells to better understand potential impacts on fertility that may be sex specific.
National Institutes of Health (NIH-NIAID)NIHNotice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-051.html09/08/202111/09/2020Epidemiology / Public Health; Life Sciences
Environmental Protection Agency (EPA)Non-NIH FederalViral Pathogen and Surrogate Approaches for Assessing Treatment Performance in Water Reusehttps://www.epa.gov/research-grants/viral-pathogen-and-surrogate-approaches-assessing-treatment-performance-water-reuse01/06/202110/29/2020Epidemiology / Public Health; Life SciencesThe U.S. Environmental Protection Agency (EPA), as part of its Science to Achieve Results (STAR) program, is seeking applications proposing to conduct research on existing and novel surrogates for the detection and monitoring of the presence of human enteric viral pathogens and surrogates in water reuse applications, where wastewater is the source water. Additionally, proposals should aim to identify quantitative reductions of infectious viral pathogens and surrogates across unit treatment processes and full treatment trains to improve viral risk assessments; viral log reduction targets; and unit process credits for water reuse applications.
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)https://grants.nih.gov/grants/guide/notice-files/NOT-TR-21-006.html03/17/202110/29/2020Epidemiology / Public Health; Life SciencesNational Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes, i.e., “coronavirus disease 2019” (COVID-19). NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial.
US Department of Agriculture (USDA)Non-NIH FederalRural Health and Safety Education Competitive Grants Program (RHSE)https://nifa.usda.gov/funding-opportunity/rural-health-and-safety-education-competitive-grants-program-rhse04/29/202110/22/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThe anticipated amount for awards in FY 2021 is approximately $4,000,000; approximately $1,000,000 of which will be for competitive external grants for eligible institutions to support the utilization of telehealth, telemedicine, and distance learning strategies for education and training in minority rural communities related to opioids or preventing spread of SARS-CoV-2 and in mitigating infection and transmission of SARS-CoV-2.
National Institutes of Health (NIH)NIHHealth Services Research on Minority Health and Health Disparities (R01 - Clinical Trial Optional)https://grants.nih.gov/grants/guide/pa-files/PAR-20-310.html11/27/2020 and 03/17/202110/12/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThe purpose of this Funding Opportunity Announcement (FOA) is to encourage innovative health services research that can directly and demonstrably contribute to the improvement of minority health and/or the reduction of health disparities at the health care system-level as well as within clinical settings.Application budgets are not limited but need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Biomedical Advanced Research and Development Authority (BARDA)Non-NIH FederalDivision of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement (revised)https://beta.sam.gov/opp/1dc80b303ceb42ca990197f19c0f7b1f/view02/03/202310/12/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborToday we face new health security threats that require breakthrough solutions. To address these new threats, ASPR and BARDA launched DRIVe. DRIVe’s mission is to accelerate innovations, and improve availability of transformative technologies and countermeasures to protect Americans from natural and intentional health security threats.
Centers for Disease Control (CDC)Non-NIH FederalEmerging Infections Network - Research for Preventing, Detecting, and Managing Travelers who Acquire Infectious Diseases Abroadhttps://www.grants.gov/web/grants/view-opportunity.html?oppId=32831712/18/202010/12/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this notice of funding opportunity (NOFO) is to support research activities that will assist with the prevention, detection, and management of international travelers who become ill during or after travel. The project must have a focus on travel and tropical medicine providers with the capability to participate in research to determine the disease prevention strategies, burden, severity, optimal diagnostics, treatment interventions, and outcomes of infectious diseases acquired while travelling abroad. This research will bridge the gap between clinical medicine and public health by assisting with improving patient care, better understanding the natural history of disease, and implementing optimal diagnostic and treatment strategies, with the ultimate outcome being an advancement in the global health security of the United States.$1M - $1.5M
National Institutes of Health (NIH-NICHD)NIHNOSI: Research on Rehabilitation Needs Associated with the COVID-19 Pandemichttps://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-031.html02/05/202110/05/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Notice of Special Interest is to encourage applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation: 1) Encourage research to address the rehabilitation needs of survivors of COVID-19; 2) Understand the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions; and 3) Understand the social, behavioral, economic, and health impact of the COVID-19 pandemic and the associated mitigation actions on people with physical disabilities.
National Science Foundation (NSF)Non-NIH FederalFuture of International Research Collaboration Post COVID-19https://www.nsf.gov/pubs/2020/nsf20132/nsf20132.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click03/31/2021 or until funds are fully obligated10/05/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis letter invites Rapid Response Research (RAPID) and EArly-concept Grants for Exploratory Research (EAGER) proposals for research to clarify lessons from the COVID-19 pandemic for international collaboration and research to strengthen international collaboration in the future. Proposals must focus on research topics unique to international engagement.RAPID: Up to $200K for 1 year; EAGER: Up to $300K for 2 years
Centers for Disease Control (CDC)Non-NIH FederalMonitoring Cause-specific School Absenteeism for Estimating Community-wide Influenza and SARS-CoV-2 Transmissionhttps://www.grants.gov/web/grants/view-opportunity.html?oppId=32925812/18/202009/30/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThe purpose of this notice of funding opportunity (NOFO) is to support a research project that aims to develop and implement an influenza-like illness (ILI)-specific student absentee monitoring system in kindergarten through twelfth grade (K-12) schools and assess its usability for early detection of influenza, SARS-CoV-2, and other respiratory pathogen transmission in schools and surrounding communities. To achieve this aim, the project team will: 1) rapidly determine the causes of school absenteeism in students across selected school district(s) over a three-year period; 2) detect within-household transmission of influenza and SARS-CoV-2 in households from which a student has been absent from school due to ILI; and 3) assess comparability between influenza-specific and SARS-CoV-2-specific student absenteeism data from the participating schools and multiple layers of complementary influenza and SARS-CoV-2 surveillance data routinely collected in the health care facilities serving the general population of this school district.$500,000 - $1,000,000
Foundation for a Smoke-free WorldFoundationCOVID-19, Smoking, and Nicotine Researchhttps://www.smokefreeworld.org/wp-content/uploads/2020/06/RFP-COVID-19_Smoking_Nicotine-Research-1.pdf12/15/202009/30/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborFor more information about this opportunity, please contact Traci Galbaugh (tlgalbaugh@ucdavis.edu), Senior Director of Foundation EngagementVaries by study type
National Institutes of Health (NIH)NIHThe Intersection of Sex and Gender Influences on Health and Disease (R01)https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-029.html11/25/202009/28/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life SciencesThe purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications on the influence and intersection of sex and gender in health and disease including:  (1) research applications that examine sex and gender factors and their intersection in understanding health and disease; and (2) research that addresses one of the five objectives from Strategic Goal 1 of the new 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women." The awards under this FOA will be administered by NIH ICs using funds that have been made available through the Office of Research on Women’s Health (ORWH) and the scientific partnering Institutes and Centers across NIH.Up to $350K direct costs per year for up to 4 years
Department of Health & Human Services (DHHS)Non-NIH FederalCommunity Health Access and Rural Transformation (CHART)https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=7783902/16/202109/28/2020Community and Social Services; Epidemiology / Public HealthCHART aligns with CMS’s Rethinking Rural Health initiative, which aims to ensure individuals in rural America have access to high quality, affordable health care by offering new and creative payment models. The CHART Model will include two tracks: 1) the Community Transformation Track and 2) the Accountable Care Organization (ACO) Transformation Track. This Notice of Funding Opportunity (NOFO) is for the Community Transformation Track only. Under the Community Transformation Track, award recipients will receive cooperative agreement funding and a programmatic framework to assess the needs of their Community (as defined in section A.4.3.1. Community Definition below) and implement health care delivery system redesign.Up to $5,000,000
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19https://grants.nih.gov/grants/guide/notice-files/NOT-MH-20-053.html12/15/202008/25/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Policy, Economics, and LaborThis Notice of Special Interest (NOSI) highlights interest in research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. While the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this NOSI is to support research to address secondary health effects of the social, behavioral, and economic changes, particularly among populations who experience health disparities and vulnerable populations through the use of digital health assessments and interventions to yield measurable near-term impact.
BARDANon-NIH FederalOperation Warp Speed Broad Agency Announcement OWS-BAA-20-01https://beta.sam.gov/opp/d3b19cfbad31430dab3880812ce2abf3/view?index=opp&preference_id=300d6387-f360-4099-8eee-52a1659952c7&page=11&sort=-modifiedDate&keywords=%22broad%20agency%20announcement%22%20%22BAA%22&date_filter_index=0&inactive_filter_values=fals08/10/2020Epidemiology & Public Health; Life SciencesOperation Ward Speed (OWS) released a broad agency announcement (BAA) to solicit pre-proposals for procurement contracts, other transaction agreements, and technology investment agreements related to Plasma or Therapeutics (based on current announcement). OWS anticipates releasing future calls and solicitations under this BAA.
PandemicTechIndustry SponsorThe PandemicTech Innovation Fellowship 2020http://www.pandemictech.com/fellowship2020/08/06/2020 begins rolling deadlines08/10/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Humanities; Life Sciences; Policy, Economics, and LaborFor more information about this opportunity, please contact Robyn Ireland (rmbireland@ucdavis.edu), Assistant Director of Corporate EngagementAwards will vary in amount between $2,000 — $20,000 based on the funding needed for each specific project. 
National Institutes of Health (NIH)NIHUrgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01)https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-20-003.html08/06/2020 begins rolling deadlines08/10/2020Epidemiology / Public Health; Life SciencesThe purpose of this urgent funding opportunity announcement is to invite applications to repurpose existing therapeutic agents to treat Coronavirus Disease 2019 (COVID-19) sequelae and associated complications that result from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. The therapeutic agent must have already completed at least a Phase I clinical trial for a different indication, and not require additional regulatory studies for the new indication prior to starting a clinical trial.Up to $9M over 3 years
Economic Development Administration (EDA)Non-NIH FederalPublic Works and Economic Adjustment Assistance Programs including CARES Act Fundinghttps://www.grants.gov/web/grants/view-opportunity.html?oppId=32169508/04/2020Community & Social Services; Policy, Economics & LaborCARES Act Recovery Assistance Projects: Successful applications will enable affected communities to respond to the impacts of the coronavirus pandemic by supporting affected businesses and communities, including by providing technical assistance to retain existing and hire new employees; by providing a range of skills-training and workforce development projects to help employees compete for high-quality jobs; and by developing and implementing strategies to diversify regional economies to create jobs in new or existing industries.Range from $150,000 to $1,000,000
Emergent VenturesAcademic Research InstituteSECOND ROUND: Emergent Ventures Fast Funding for COVID-19 Sciencehttps://fastgrants.org/07/21/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Humanities; Life Sciences; Policy, Economics, and LaborIf you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, the Emergent Ventures project at the Mercatus Center invites you to apply for a Fast Grant. A Fast Grant must be used solely to expedite COVID-19-related science, but the area of research is open. Fast grants are $10k to $500k and decisions are made in under 14 days.Up to $500,000
National Oceanic and Atmospheric Administration (NOAA)Non-NIH FederalAtmospheric Chemistry, Carbon Cycle, and Climate (AC4) Program - Climate Program Office 2021https://www.grants.gov/web/grants/search-grants.html?keywords=NOAA-OAR-CPO-2021-200638911/30/202007/21/2020Community & Social Services; Data Science, AI & Computing; Epidemiology & Public Health; Life SciencesThis year, AC4 has two competitions, and the foci are: Impacts of COVID-19 pandemic; and Urban atmospheric composition as related to the AEROMMA field campaign.Proposals should not exceed $200,000 per year
CiscoIndustry SponsorPandemic/COVID19 Science, Technology and Social Impacthttps://research.cisco.com/research#rfp-20200407/16/2020Data Science, AI & Computing; Engineering; Epidemiology & Public HealthFor more information about this opportunity, please contact Scott Stevenson (swstevenson@ucdavis.edu), Associate Director of Corporate EngagementNo limitations
National Institutes of Health (NIH - NIAID)NIHLimited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10)https://grants.nih.gov/grants/guide/pa-files/PAR-20-256.html07/13/2020 begins rolling deadline07/15/2020Community & Social Services; Epidemiology & Public Health; Life SciencesThe purpose of this public health emergency funding opportunity is to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19. This program will ensure that adequate protective equipment is available to directly assist in safely carrying out the clinical activities and direct interactions with the patients participating in the trial. Eligibility is limited to recipients conducting COVID-related clinical research and clinical studies supported by NIAID’s emergency appropriation provided by “The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020” and “The Coronavirus Aid, Relief and Economic Security (CARES) Act”.It is expected that applicants will employ the most economical approaches, including securing academic discounts, to formulate a cost-effective budget while meeting users' needs.
National Institutes of Health (NIH - NIAID)NIHNotice of Special Interest (NOSI) Regarding the Availability of Emergency Competitive Revisions for Select Research Activities Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-059.html07/01/202107/13/2020Epidemiology & Public Health; Life SciencesNIAID is issuing this Notice of Special Interest (NOSI) to highlight very specific and limited needs for Competitive Revision applications to active NIAID grants in order to further build the infrastructure that NIAID needs to support the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) research response. This NOSI replaces NOT-AI-20-034 which was rescinded with this issuance of this Notice.
National Institutes of Health (NIH - NIDDK)NIHMechanistic Studies of the Interaction Between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01)https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-021.html12/16/202007/13/2020Epidemiology & Public Health; Life SciencesThe purpose of this Funding Opportunity Announcement (FOA) is to support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes in organs, tissues, and biological systems of specific interest to NIDDK. These include diabetes and other metabolic diseases, obesity, and endocrine, digestive, liver, pancreas, kidney, urological, and hematologic tissues and diseases.Up to $750,000 direct costs over 3 years
Open Road AllianceFoundationCharitable Grantshttps://openroadalliance.org/covid-19/06/26/2020Community & Social Services; Data Science, AI & Computing; Engineering; Epidemiology & Public Health; Humanities; Life Sciences; Policy, Economics & LaborFor more information about this opportunity, please contact Traci Galbaugh (tlgalbaugh@ucdavis.edu), Senior Director of Foundation Engagement
Mercatus CenterAcademic Research InstituteCOVID-19 Response: A Call for Ideashttps://www.mercatus.org/features/covid-19-response-call-ideas04/27/2020 begins rolling deadline05/18/2020Behavior & Psychology; Community & Social Services; Data Science, AI & Computing; Epidemiology & Public Health; Humanities; Life Sciences; Policy, Economics & LaborThe Mercatus Center, building on its COVID-19 policy brief series, welcomes proposals for policy briefs, working papers, and articles that address the next round of challenges facing the United States and other countries in the response to the pandemic. See the solicitation for the specific questions of interest in the topics of restarting and reopening, institutional challenges, health and science policy, economic and regulatory policy, and monetary policy.
Draper Richards Kaplan FoundationFoundationCOVID-19 Urgent Response Initiativehttps://drive.google.com/file/d/1Dcj2zuFKE72caEBYz5ADOLDWeci802cD/view05/18/2020Behavior & Psychology; Community & Social Services; Data Science, AI & Computing; Engineering; Humanities; Policy, Economics & Labor; InstructionDRK is ready to find, fund, and support the people and ideas that are tackling the most acute and time-critical social problems caused by the Covid-19 pandemic right now. We want to help jumpstart projects that can realistically deploy within 30 days. We are best positioned to help work on the social problems caused by the pandemic versus direct mitigation via medical and scientific efforts. We will filter potential investments through the lens of urgency: Can this make large impact at scale? Can it be deployed quickly? And can DRK be catalytic in making that happen?Anticipated Range $50K-$100K
CETF and Rockefeller Philanthropy AdvisorsFoundationCOVID-19 Early Treatment Fund (CETF)http://www.treatearly.org/apply-for-funding05/12/2020Epidemiology & Public Health; Life SciencesFor more information about this opportunity, please contact Charlie Lemcke (cwlemcke@ucdavis.edu), Assistant Director of Corporate EngagementUp to $1M
Economic Development Administration (EDA)Non-NIH FederalEDA CARES Act Recovery Assistancehttps://www.eda.gov/coronavirus/05/12/2020Community & Social Services; Policy, Economics & LaborThe Coronavirus Aid, Relief, and Economic Security (CARES) Act provides the EDA with $1.5 billion for economic development assistance programs to help communities prevent, prepare for, and respond to coronavirus. EDA CARES Act Recovery Assistance provides a wide-range of financial assistance to communities and regions as they respond to and recover from the impacts of the pandemic. This includes: 1) Planning and Technical Assistance, 2) Construction of Infrastructure and Other Economic Development Projects, 3) Innovation Grants, and 4) Capitalization and Recapitalization of Revolving Loan Funds. Check that the proposed project fits the scope with the EDA regional office; applications reviewed on rolling basis.Typically up to $1,000,000
National Institutes of Health (NIBIB)NIHRapid Acceleration of Diagnostics (RADx)https://www.poctrn.org/radx04/28/2020 begins rolling deadline04/29/2020Epidemiology / Public Health; Life SciencesThe National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches.Varies by Phase
National Institutes of Health (NIH)NIHAll open COVID-19 calls and Notices of Special Interest (NOSIs) from the Instituteshttps://grants.nih.gov/policy/natural-disasters/corona-virus.htm04/24/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and Labor; Education and TrainingThis page on the NIH website contains a table of all open COVID-19 calls and Notices of Special Interest (NOSIs) from the Institutes, in addition to other useful information. At this time there are too many NIH NOSIs to add to this table.Various
Henry Wheeler Center for Emerging and Neglected Diseases (CEND)University of CaliforniaCOVID Catalyst Fundinghttp://cend.globalhealth.berkeley.edu/covid-catalyst-rapid-funding-accelerate-covid-19-research/04/20/2020Epidemiology / Public Health; Life SciencesThe Covid Catalyst fund will provide catalytic seed funding for high-risk projects, as well as catalytic bridge funding for lower risk projects that likely will be successful in attracting government funding long-term. We will be able to fund projects for 3-6 months at a time or until a major milestone is reached. High-risk ideas that turn out to be not feasible should be allowed to fail rapidly so that another approach can be taken. Once the milestone is reached, repeat funding is possible to continue towards implementation.Up to $100,000
National Institutes of Health (NIH)NIHEmergency Competitive Revision to Existing NIH Awardshttps://grants.nih.gov/grants/guide/pa-files/PA-20-135.html04/10/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster. Applications for Emergency Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award. Only applications submitted in response to an Emergency Notice of Special Interest (NOSI) published by an IC will be allowed to apply to this FOA.
GoogleIndustry SponsorGoogle Cloud research creditshttps://edu.google.com/programs/credits/research/?modal_active=none04/09/2020Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Amy Skehan (arskehan@ucdavis.edu), Assistant Vice Chancellor of Foundation and Corporate Engagement
BARDANon-NIH FederalCoronaWatch/TechWatch Medical Countermeasureshttps://www.medicalcountermeasures.gov/request-barda-techwatch-meeting/04/07/2020Engineering; Life SciencesTo enable a rapid-response to the COVID-19 outbreak, BARDA has repurposed its existing TechWatch program to focus on COVID-19 medical countermeasures. These CoronaWatch submissions and meetings aim to give innovators and innovative companies a government-wide platform to discuss their ideas with U.S. government experts, and seek partnership opportunities with a wide range of potential federal partners. BARDA is particularly interested in products and technologies that have progressed into or beyond non-clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. Information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak are sought.
California Institute for Regenerative Medicine (CIRM)State of CaliforniaCIRM Rapid Research Fundshttps://www.cirm.ca.gov/about-cirm/newsroom/press-releases/03272020/stem-cell-agency-board-approves-5-million-emergency04/07/2020Epidemiology / Public Health; Life SciencesCIRM is issuing this special announcement to support promising discovery, preclinical and clinical trial stage projects that could quickly advance treatments to COVID-19 patients in need.Varies by Project Stage
DoD-Joint Acquisition Task Force (JATF)Non-NIH FederalCOVID-19 Request for Information (RFI)https://www.afwerx.af.mil/coronavirus.html04/07/2020Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Policy, Economics, and LaborDoD JATF is seeking input to shape its COVID-19 funding decisions focused on the accelerated ramp-up of production capacity for critical healthcare products such as masks, ventilators, test kits, and vaccines. JATF Focus Areas: 1) Combating Spread, 2) Welfare of Citizens, 3) Readiness, 4) Logistics, 5) Industrial base impacts, 6) Medical, 7) Other
PfizerIndustry SponsorCompetitive Grants Programhttps://www.pfizer.com/purpose/independent-grants/competitive-grants04/07/2020Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Jamie Shattuck (jkshattuck@ucdavis.edu), Senior Director of Corporate Engagement
Allen Institute for AIPublic-Private PartnershipCOVID-19 Open Research Dataset Challengehttps://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge04/02/2020Data Science, AI, ComputingFor more information about this opportunity, please contact Robyn Ireland (rmbireland@ucdavis.edu), Assistant Director of Corporate Engagement$1,000 per task
BARDANon-NIH FederalBARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement: Molecular Diagnostics and Nonclinical Assayshttps://beta.sam.gov/opp/b4f7923443a448218d369209723141c5/view?keywords=BAA-20-100-SOL-0002%20&sort=-relevance&index&is_active=true&page=102/03/202104/02/2020Engineering; Life SciencesBiomedical Advanced Research and Development Authority (BARDA) is looking for: Molecular diagnostic assay for SARS-CoV-2 virus on existing FDA-cleared platform, Point-of-care diagnostic assay for detection of SARS-CoV-2 virus, Diagnostic assay for detection of COVID-19 disease, Nonclinical model development and screening for SARS-CoV-2 virus, Alternate vaccine delivery/administration and adjuvants, and Advanced manufacturing technologies. Rolling deadline.
DoE OSTP IBMPublic-Private PartnershipCOVID-19 High Performance Computing Consortiumhttps://covid19-hpc-consortium.org/04/02/2020Behavior and Psychology; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life SciencesThe COVID-19 High Performance Computing Consortium helps aggregate computing capabilities from the world's most powerful and advanced computers to help COVID-19 researchers execute complex computational research programs to help fight the virus.  Researchers seeking to access the Consortium’s resources should submit a simple project proposal that will be reviewed for potential impact, computational feasibility, overall resource requirements and timeline.
Gates Foundation, Wellcome Trust, Mastercard, & CZIFoundationCOVID-19 Therapeutics Acceleratorhttps://www.therapeuticsaccelerator.org/04/02/2020Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Traci Galbaugh (tlgalbaugh@ucdavis.edu), Senior Director of Foundation Engagement
Ginkgo BioworksIndustry SponsorFree Access to Ginkgo Platformhttps://www.ginkgobioworks.com/2020/03/17/ginkgo-commits-25m-of-free-access-to-our-platform-for-partner-covid-19-projects/04/02/2020Data Science, AI, Computing; Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Jamie Shattuck (jkshattuck@ucdavis.edu), Senior Director of Corporate Engagement
NIH-NIAID & NIANIHInvestigator Initiated Extended Clinical Trial (R01)https://grants.nih.gov/grants/guide/pa-files/PAR-20-139.html01/13/2021 next deadline03/30/2020Epidemiology / Public Health; Life SciencesThis Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of one of the participating ICs. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.